Céline S. Gonçalves

Citata da

	Tutte	Dal 2019
Citazioni	789	647
Indice H	18	17
i10-index	20	19

160

120

20152016201720182019202020212022202320248 38 35 53 61 116 132 128 146 64

Accesso pubblico

Visualizza tutto

23 articoli

4 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Bruno M. CostaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of MinhoEmail verificata su med.uminho.pt
Carmen JeronimoPortuguese Oncology Institute of PortoEmail verificata su ipoporto.min-saude.pt
Rui HenriqueProfessor of Pathology, University of PortoEmail verificata su icbas.up.pt
Rui Manuel ReisBarretos Cancer Hospital (Brazil) and Minho University (Portugal)Email verificata su hcancerbarretos.com.br
Nuno SousaProfessor, School of Medicine, ICVS, UMinho, PortugalEmail verificata su med.uminho.pt
Ana Xavier-MagalhaesUCSFEmail verificata su ucsf.edu
Filipa Quintela VieiraESTSP, IPO, ICBASEmail verificata su eu.ipp.pt
João Ramalho CarvalhoDivision of Oncogenomics - The Netherlands Cancer InstituteEmail verificata su nki.nl
Pedro Costa-PinheiroNCI Postdoctoral Fellow @ University of PennsylvaniaEmail verificata su pennmedicine.upenn.edu
Fatima BaltazarUniversity of MinhoEmail verificata su med.uminho.pt
Ana Isabel OliveiraPostdoctoral Fellow, VIB - KU Leuven Center for Cancer Biology (CCB)Email verificata su kuleuven.vib.be
Miguel RochaAssociate Professor, Dept. Informatics and Centre Biological Engineering, Universidade do MinhoEmail verificata su di.uminho.pt
Vera Miranda-GonçalvesResearch Center of Portuguese Oncology Institute of PortoEmail verificata su ipoporto.min-saude.pt
Sara CorreiaPost-doctoral researcherEmail verificata su deb.uminho.pt
P. ARNAUDGReD CNRS & Université Clermont AuvergneEmail verificata su uca.fr
Ana J RodriguesUNIVERSITY OF MINHO, ICVS/School of MedicineEmail verificata su MED.UMINHO.PT
Cláudia FariaInstituto de Educação da Universidade de LisboaEmail verificata su ie.ul.pt
Carlos CustodiaInstituto de Medicina Molecular, Faculdade de Medicina da Universidade de LisboaEmail verificata su medicina.ulisboa.pt
Ricardo TaipaNeuropathology Department and Portuguese Brain Bank, CHUdSA, PortoEmail verificata su chporto.min-saude.pt
Luisa PintoLife and Health Sciences Research Institute (ICVS), School of Medicine, University of MinhoEmail verificata su med.uminho.pt

Segui

Céline S. Gonçalves

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho

Email verificata su med.uminho.pt

Neuro-Oncology Transcriptomic Signaling pathways etc.


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
MicroRNA-375 plays a dual role in prostate carcinogenesis P Costa-Pinheiro, J Ramalho-Carvalho, FQ Vieira, J Torres-Ferreira, ... Clinical epigenetics 7 (1), 1-14, 2015	103	2015
Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication AS Pires-Luís, M Vieira-Coimbra, FQ Vieira, P Costa-Pinheiro, ... Epigenetics 10 (11), 1033-1043, 2015	64	2015
A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide M Pojo, CS Gonçalves, A Xavier-Magalhães, AI Oliveira, T Gonçalves, ... Oncotarget 6 (10), 7657, 2015	58	2015
Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer D Almeida-Rios, I Graça, FQ Vieira, J Ramalho-Carvalho, E Pereira-Silva, ... Oncotarget 7 (33), 53018, 2016	52	2016
A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97 J Ramalho-Carvalho, CS Gonçalves, I Graça, D Bidarra, E Pereira-Silva, ... Clinical epigenetics 10 (1), 1-15, 2018	48	2018
MicroRNA-30a-5p me: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples G Outeiro-Pinho, D Barros-Silva, E Aznar, AI Sousa, M Vieira-Coimbra, ... Journal of Experimental & Clinical Cancer Research 39 (1), 1-11, 2020	43	2020
Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis A Xavier-Magalhães, AI Oliveira, JV de Castro, M Pojo, CS Gonçalves, ... Journal of neuro-oncology 132 (1), 27-34, 2017	42	2017
HOX gene cluster (de) regulation in brain: from neurodevelopment to malignant glial tumours CS Gonçalves, E Le Boiteux, P Arnaud, BM Costa Cellular and Molecular Life Sciences 77 (19), 3797-3821, 2020	41	2020
WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma CS Gonçalves, JV de Castro, M Pojo, EP Martins, S Queirós, E Chautard, ... Theranostics 8 (17), 4805, 2018	38	2018
The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma A Xavier-Magalhães, CS Gonçalves, A Fogli, T Lourenço, M Pojo, ... Oncotarget 9 (21), 15740, 2018	33	2018
Overexpression of circulating MiR-30b-5p identifies advanced breast cancer H Estevão-Pereira, J Lobo, S Salta, M Amorim, P Lopes, M Cantante, ... Journal of Translational Medicine 17 (1), 435, 2019	31	2019
Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting J Vieira de Castro, CS Gonçalves, A Hormigo, BM Costa International Journal of Molecular Sciences 21 (15), 5278, 2020	28	2020
Unravelling the anticancer potential of functionalized chromeno [2, 3-b] pyridines for breast cancer treatment S Oliveira-Pinto, O Pontes, D Lopes, B Sampaio-Marques, MD Costa, ... Bioorganic Chemistry, 103942, 2020	25	2020
Impact of TGF-β1-509C/T and 869T/C polymorphisms on glioma risk and patient prognosis J Vieira de Castro, CS Gonçalves, S Costa, P Linhares, R Vaz, R Nabiço, ... Tumor Biology 36 (8), 6525-6532, 2015	23	2015
A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis CS Gonçalves, A Xavier‐Magalhães, EP Martins, AA Pinto, MM Pires, ... Molecular oncology 14 (6), 1224-1241, 2020	22	2020
Sirtuins’ Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion S Monteiro-Reis, A Lameirinhas, V Miranda-Gonçalves, D Felizardo, ... Cancers 12 (5), 1066, 2020	22	2020
SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization MJ Ferreira, AS Pires-Luís, M Vieira-Coimbra, P Costa-Pinheiro, ... Epigenetics, 1-8, 2018	22	2018
MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma V Miranda-Gonçalves, CS Gonçalves, S Granja, J Vieira de Castro, ... Cancers 13 (14), 3468, 2021	21	2021
Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models CS Gonçalves, A Xavier-Magalhães, M Pojo, AI Oliveira, S Correia, ... Genomics data 5, 54-58, 2015	17	2015
Fucoidan/chitosan nanoparticles functionalized with anti-ErbB-2 target breast cancer cells and impair tumor growth in vivo C Oliveira, CS Gonçalves, EP Martins, NM Neves, RL Reis, BM Costa, ... International Journal of Pharmaceutics 600, 120548, 2021	16	2021

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori